PlatinumÔÇÉcontaining regimens for metastatic breast cancer

Source:
Cochrane Database of Systematic Reviews
Publisher:
Cochrane Database of Systematic Reviews
Publication date:
23 June 2017

Abstract

High-quality evidence from 24 RCTs (n=4418) concludes in women with metastatic breast cancer who do not have triple-negative disease, there is little or no survival benefit and excess toxicity from platinum-based regimens.